The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS).

dc.contributor.author	Ogutu, EO.
dc.contributor.author	Amayo, EO.
dc.contributor.author	Okoth, F.
dc.contributor.author	Lule, GN.
dc.date.accessioned	2013-04-08T07:52:18Z
dc.date.available	2013-04-08T07:52:18Z
dc.date.issued	1990
dc.identifier.citation	East Afr Med J.	en
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/15497
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pubmed/2390958
dc.description.abstract	Forty one consecutive patients (24 males and 17 females) with AIDS had their blood assayed for HBsAg, anti-HBs and anti-HBc by Reversed Passive Haemagglutination (RPHA), Passive Haemagglutination (PHA) and Enzyme Linked Immunosorbent Assay (ELISA) techniques respectively. 5 (12.2%) were found positive for HBsAg. 10 (24.4%) for anti-HBs and 31 (75.6%) for anti-HBc. 32 (78%) out of 41 patients with AIDS had serological evidence of exposure to hepatitis B virus (HBV). The prevalence of HBsAg found in this study is not different from what has been found in the Kenyan community without AIDS, while that of anti-HBs is much lower than what has been reported in the general community	en
dc.language.iso	en	en
dc.relation.ispartofseries	Vol. 67(5):355-8.(1990);
dc.title	The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS).	en
dc.type	Article	en
local.publisher	Department of Medicine. College of Health Sciences. University of Nairobi	en